Tech Company Financing Transactions

Gritstone Oncology Funding Round

Casdin Capital, Clarus and Frazier Healthcare Partners participated in a $102 million Series A funding round for Gritstone Oncology. The funding round was announced by the company on 10/21/2015.

Transaction Overview

Company Name
Announced On
10/21/2015
Transaction Type
Venture Equity
Amount
$102,000,000
Round
Series A
Proceeds Purpose
The financing will support discovery and development of novel tumor-specific neo-antigen (TSNA) based immunotherapies, with an initial focus on lung cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5959 Horton St. 300
Emeryville, CA 94608
USA
Email Address
Overview
Gritstone Oncology is a cancer immunotherapy company developing next-generation personalized cancer therapeutics.
Profile
Gritstone Oncology LinkedIn Company Profile
Social Media
Gritstone Oncology Company Twitter Account
Company News
Gritstone Oncology News
Facebook
Gritstone Oncology on Facebook
YouTube
Gritstone Oncology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andrew Allen
  Andrew Allen LinkedIn Profile  Andrew Allen Twitter Account  Andrew Allen News  Andrew Allen on Facebook
Chief Financial Officer
Jean-Marc Bellemin
  Jean-Marc Bellemin LinkedIn Profile  Jean-Marc Bellemin Twitter Account  Jean-Marc Bellemin News  Jean-Marc Bellemin on Facebook
Chief Medical Officer
Raphaël Rousseau
  Raphaël Rousseau LinkedIn Profile  Raphaël Rousseau Twitter Account  Raphaël Rousseau News  Raphaël Rousseau on Facebook
Chief Scientific Officer
Karin Jooss
  Karin Jooss LinkedIn Profile  Karin Jooss Twitter Account  Karin Jooss News  Karin Jooss on Facebook
Chief Technical Officer
Roman Yelensky
  Roman Yelensky LinkedIn Profile  Roman Yelensky Twitter Account  Roman Yelensky News  Roman Yelensky on Facebook
VP - Bus. Development
Matthew Hawryluk
  Matthew Hawryluk LinkedIn Profile  Matthew Hawryluk Twitter Account  Matthew Hawryluk News  Matthew Hawryluk on Facebook
VP - Regulatory Affairs
Erin Jones
  Erin Jones LinkedIn Profile  Erin Jones Twitter Account  Erin Jones News  Erin Jones on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/21/2015: Betabrand venture capital transaction
Next: 10/21/2015: Silk Road Medical venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary